Audax Private Equity (“Audax”), a leading alternative investment manager and capital partner, announced that it has made a growth investment in Pyramid Laboratories, Inc. (“Pyramid” or the “Company”) to support the continued growth of the Company’s clinical and commercial biologics and advanced therapeutics manufacturing and service operations. Founded in 1988 by Medhat Gorgy and headquartered in Costa Mesa, CA, Pyramid is a leading drug product contract development and manufacturing organization (“CDMO”). The company provides formulation development, analytical and stability testing, as well as aseptic fill-finish manufacturing services focused on large molecule therapeutics.
Read the full article: Audax Private Equity Announces Growth Investment in Pyramid Laboratories, Inc. //
Source: https://www.businesswire.com/news/home/20230418005044/en/Audax-Private-Equity-Announces-Growth-Investment-in-Pyramid-Laboratories-Inc.